Primary pulmonary hepatoid carcinoma: Report of a case and review of the literature  by Lin, Shiou-Fu et al.
Kaohsiung Journal of Medical Sciences (2013) 29, 512e516Available online at www.sciencedirect.com
journal homepage: http: / /www.kjms-onl ine.comCASE REPORTPrimary pulmonary hepatoid carcinoma: Report
of a case and review of the literatureShiou-Fu Lin a, Wen-Hu Hsu b, Teh-Ying Chou a,c,*aDepartment of Pathology and Laboratory Medicine, Taipei Veterans General Hospital,
Taipei, Taiwan
bDepartment of Surgery, Taipei Veterans General Hospital, Taipei, Taiwan
c Institute of Clinical Medicine, School of Medicine, National Yang-Ming University,
Taipei, TaiwanReceived 28 June 2012; accepted 8 August 2012
Available online 6 April 2013KEYWORDS
Alpha-fetoprotein;
Hepatoid carcinoma;
Lungs* Corresponding author. Department
Medicine, Taipei Veterans General Ho
E-mail address: tychou@vghtpe.go
1607-551X/$36 Copyright ª 2013, Kao
http://dx.doi.org/10.1016/j.kjms.201Abstract Hepatoid carcinoma is a rare malignancy defined as extrahepatic primary alpha-
fetoprotein-producing carcinomamorphologically resembling hepatocellular carcinoma. It is ex-
tremely rare in the lungs,with ambiguous pathological descriptions and variable prognosis. Here-
in, we present the case of a 66-year-oldmanwith a primary pulmonary hepatoid carcinoma in his
right upper lungwho received complete curative surgical resection and adjuvant chemotherapy.
No signs of recurrence or distant metastasis have been observed for 57 months postoperation. In
addition, the literature is reviewed and the pathological diagnostic pitfalls are discussed.
Copyright ª 2013, Kaohsiung Medical University. Published by Elsevier Taiwan LLC. All rights
reserved.Introduction
Hepatoid carcinoma is defined as a primary alpha-
fetoprotein (AFP)-producing carcinoma composed of neo-
plastic cells morphologically resembling hepatocellular
carcinoma [1e3]. Pulmonary hepatoid carcinoma is
extremely rare, with less than 20 cases being reported.
Herein, we present a case of primary pulmonary hepatoidof Pathology and Laboratory
spital, Taipei 112, Taiwan.
v.tw (T.-Y. Chou).
hsiung Medical University. Publish
3.01.007carcinoma with description of complete clinical and
pathological findings, outcome after surgical resection, and
literature review.
Case report
A 66-year-old male presented with productive cough for 5
years. Recently the symptoms progressed with exertional
dyspnea. There was a history of smoking one pack of ciga-
rettes per day for 40 years. He had rheumatoid arthritis
with regular medication and was a hepatitis B virus carrier
for 30 years. He came to the hospital for health examina-
tion and a chest X-ray showed a mass lesion at the righted by Elsevier Taiwan LLC. All rights reserved.
Figure 1. (A) Chest radiograph demonstrated a right upper lobe mass (arrow). (B) Chest computed tomography demonstrated
a soft tissue mass (arrow) measuring 7.3 cm in greatest dimension in the right upper lobe.
Pulmonary hepatoid carcinoma 513upper lung field with tracheal deviation to the left side
(Fig. 1A). The AFP level was 8686 ng/mL, while the other
tumor markers, such as squamous cell carcinoma antigen,
carcinoembryonic antigen (CEA), and human chorionic
gonadotropin were within normal ranges.
During admission no abnormality was found in the blood
cell count and biochemistry measurements, such as levels
of aspartate aminotransferase, alanine aminotransferase,
alkaline phosphatase, and blood urea nitrogen-to-
creatinine ratio. A chest computer tomography (CT)
revealed a soft tissue mass measuring 7.3  5.6  3.3 cm
over the right upper lobe of the lung with mediastinal
lymphadenopathy (Fig. 1B). No definite focal lesion in the
visible parts of liver parenchyma, spleen, pancreas, gall-
bladder, bilateral adrenal glands, and kidneys was
observed. An abdominal sonography was performed, which
showed few polyps in the gallbladder, but no abnormality
was found either in the liver or stomach. Results of a brain
CT and bone scan demonstrated no distant metastasis. The
whole-body positron emission tomography/CT showedFigure 2. (A) Right upper lobe mass with adhesion to the chest w
gray yellowish firm part with focal necrosis and consolidation in tha huge mass lesion with central photopenic uptake in the
right upper lobe of the lung with suspicious mediastinal
metastatic lymphadenopathy. The clinical staging was
cT3N2M0. The patient received curative surgical resection
on September 4, 2007.
During exploratory thoracotomy, a 12  6  6 cm mass
over the right upper lobe with adhesion to the chest wall
was found (Fig. 2A). Obstructive pneumonitis with abscess
formation was noted in the region peripheral to the tumor.
A right upper lobe lobectomy with the dissection of radical
lymph nodes was performed.
On gross examination, the tumor showed central yel-
lowish gray firm part measuring 7.4  6.0  4.8 cm with
focal necrosis and consolidation in the peripheral region
(Fig. 2B). Visceral pleural invasion with chest wall soft tis-
sue adhesion was found. A microscopic analysis showed that
the tumor cells were arranged in predominantly trabecular
and sheet-like growth patterns (Fig. 3A) with rare pseudo-
glandular areas (Fig. 3B). No tubular or papillary adeno-
carcinoma was found in the extensively sampled specimen.all. (B) The tumor measuring 7.4  6.0  4.8 cm showed central
e periphery.
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eosinophilic cytoplasm and central hyperchromatic nuclei
with prominent nucleoli, resembling hepatocellular carci-
noma. There were frequent mitotic figures, up to 24 per 10
high power fields. Periodic acideSchiff-positive, diastase-
resistant hyaline globules were seen (Fig. 3C). Extensive
necrosis is noted. The tumor invaded the chest wall, but all
sampled lymph nodes were free of tumor involvement. The
tumor cells were immunoreactive for cytokeratins (AE1/Figure 3. (A) Tumor cells arranged in predominantly trabecula
carcinoma with focal necrosis. Hematoxylin and eosin stain (H&E)
riodic acideSchiff (PAS)-positive, diastase-resistant hyaline globules
positive alpha-fetoprotein (AFP). AFP immunohistochemical stain,
glypican-3. Glypican-3 immunohistochemical stain, 400. (F) Cana
polyclonal carcinoembryonic antigen (pCEA). pCEA immunohistochAE3), AFP (Fig. 3D), and glypican-3 (Fig. 3E) diffusely, but
negative for CK7, CK20, TTF-1, hepatocyte paraffin 1 (Hep
Par 1), and neuroendocrine markers, such as chromogranin
A, synaptophysin, and CD56. Canalicular patterns were
demonstrated by the immunohistochemical staining with
polyclonal antibodies to CEA (pCEA) (Fig. 3F). No intra-
cytoplasmic mucin vacuoles were demonstrated by the
mucicarmine stain. The tumor was diagnosed as large cell
carcinoma with prominent hepatoid differentiation,r and sheet-like growth patterns, resembling hepatocellular
, 400. (B) Pseudoglandular pattern. H&E stain, 400. (C) Pe-
. PAS stain, 400. (D) Immunohistochemistry revealed diffusely
400. (E) The tumor cells are immunoreactive (positive) for
licular patterns demonstrated by the immunohistochemistry of
emical stain, 200.
Figure 4. Level of serum alpha-fetoprotein (AFP) level
(surgery on September 4, 2007).
Pulmonary hepatoid carcinoma 515compatible with hepatoid carcinoma. The pathological
staging was pT3N0M0, stage IIB.
The patient received postoperative oral vinorelbine
(Navelbine) and platin-based chemotherapy for a period of
6 months. The AFP level dropped dramatically after the
surgery and gradually decreased to normal level after the
chemotherapy (Fig. 4). The patient received regular out-
patient follow-up and no local recurrence or distant
metastasis was found after 4 years.
Discussion
Pulmonary hepatoid adenocarcinoma, first described by
Ishikura et al., is defined as an AFP-producing carcinoma
containing a mixture of tubular or papillary adenocarci-
noma with a sheet-like or trabecular proliferation of neo-
plastic cells. The tumor cells contain abundant eosinophilic
cytoplasm, centrally located nuclei, resembling those of
hepatocellular carcinoma cells, as well as hyaline globules
[4]. Histologically, the tubular or papillary componentTable 1 Selected pulmonary hepatoid carcinomas in the literat
Case Tumor
site
Pathology
review
Size (cm) Serum A
(ng/mL
1 (67/M) LUL Ad 8.0 160,000
2 (66/M) RLL Large 11.0 88,000
3 (40/M) RUL Ad 9.0 3090
4 (55/M) RUL Ad 5.0 2123
5 (73/M) LUL Ad 6.0 1039
6 (36/M) LUL Ad 10.0 11,600
7 (63/M) RUL Large 8.0 14,000
8 (82/M) LLL Large 3.5 Normal
9 (55/M) RUL Ad 6.0 89a
10 (71/M) RLL Large 10.5 9826
11 (50/M) RUL Largeb 6.0 Normal
12 (64/M) RUL Large 7.5 673
13 (52/M) LUL Ad 12 5000
14 (66/M) RUL Large 7.4 8868
A Z alive; ad Z adenocarcinoma; D Z died of disease; large Z large
mo Z months; NA Z data not available; RLL Z right lower lobe; RU
a Serum level after surgery.
b No tubular or papillary adenocarcinomatous component describedrequired for the diagnosis of adenocarcinoma was not
present in our case. Instead, the hepatocellular-like com-
ponent including trabecular or sheet-like growth patterns
with evidence of AFP-producing cells is essential for the
histological diagnosis of hepatoid carcinoma. Although
Ishikura et al. suggested to find the associated tubular/
papillary adenocarcinomatous portion in a large cell carci-
noma composed of large, eosinophilic cells with AFP pro-
duction in order to fulfill the diagnostic criteria of hepatoid
adenocarcinoma, we propose that the large cell carcinoma
mainly composed of prominent AFP-producing hepatoid
component alone is qualified for the diagnosis of hepatoid
carcinoma regardless of the adenocarcinomatous compo-
nent, as described in several previous reports [1e3].
AFP is a fetal protein normally produced in liver, yolk
sac, and gastrointestinal tract, but not in the lungs [5]. In
adults, it is a tumor marker for liver cancer, yolk sac tumor,
and certain gastrointestinal tumors. AFP production in the
tumor cells is evident in all such reported cases by immu-
nohistochemical analysis. In addition, expression of Hep Par
1, a monoclonal antibody considered almost specific for
normal and neoplastic hepatocytes, had been demon-
strated in hepatoid adenocarcinoma of the gastrointestinal
tract [6], but only one previous study reported its expres-
sion in a pulmonary tumor [7]. Expression of glypican-3,
a placental and hepatic surface heparin sulfate proteogly-
can expressed specifically in the fetal liver and malignant
neoplasms of hepatocyte lineage, has not been studied in
pulmonary hepatoid carcinoma previously. In AFP-
producing gastric carcinoma, glypican-3 was suggested to
be a sensitive marker for AFP-producing gastric carcinomas
and its hepatoid component [8]. Tumor cells of our case
show diffuse glypican-3 immunoreactivity, but its clin-
icopathological significance needs further study to clarify.
Clinically, exclusion of metastatic hepatocellular carci-
noma or hepatoid carcinoma from extrahepatic sites is of
crucial importance [4]. It is very difficult to differentiateure.
FP
)
Stage Prognosis Reference (year)
IV 16 mo, D Yasunami et al. [4] (1981)
IV 6 mo, D Yokoyama et al. [4] (1981)
IV 14 mo, D Miyake et al. [4] (1986)
IIIA 4 d, D Miyake et al. [4] (1986)
IV 19 mo, D Miyake et al. [4] (1987)
IIIB 7 mo, D Arnould et al. [9] (1997)
IV 11 mo, D Nasu et al. [2] (1997)
IB 7 y, A Carlinfante et al. [1] (2000)
IIA 30 mo, A Hayashi et al. [10] (2002)
IIIA 12 mo, D Hiroshima et al. [3] (2002)
IIB 45 mo, A Wu et al. [11] (2007)
IIB NA Kishimoto et al. [7] (2008)
NA 2 mo, A Mokrim et al. [12] (2011)
IIB 4 y, A Present case
r cell carcinoma; LLL Z left lower lobe; LUL Z left upper lobe;
L Z right upper lobe; y Z years.
.
516 S.-F. Lin et al.when primary hepatoid carcinoma metastasizes to the liver,
and therefore preoperative survey is important to obtain
the diagnosis of primary pulmonary hepatoid carcinoma.
Decreasing AFP level after the surgical resection of the
primary tumor is significantly correlated with the subse-
quent management and follow-up.
In the English literature, there are 14 cases of primary
pulmonary hepatoid carcinoma and hepatoid adenocarci-
noma without liver metastasis [1e4,7,9e12] (Table 1). All
cases reported were male, with ages ranged from 35 to 82
years (mean age: 60 years). The tumor sizes range from
3.5 to 12 cm in the largest dimension with a mean size of
7.85 cm. Most cases are located at upper lung fields. In
comprehensive review of the pathological descriptions of
the reported cases, all cases contained hepatoid com-
ponents with AFP-producing cells, but seven cases
including our case had no or scarce tubular/papillary
adenocarcinomatous proportion. The AFP levels ranged
from normal (two cases) to 160,000 ng/mL, but the AFP
production was evident by immunohistochemical analysis
in the cases with normal AFP level. Previously reported
cases of hepatoid carcinoma showed poor prognosis [4].
However, recently reported cases [1,10,11] and our case
that presented at an earlier stage when receiving surgery
and/or chemotherapy had better prognosis. Pathological
staging may be the most important prognostic factor in
hepatoid carcinoma similar to the other nonsmall cell
lung cancers.
In conclusion, we have reported a case of primary pul-
monary hepatoid carcinoma with typical clinicopathological
features. The prognosis may be correlated with the
pathological staging, but more data are needed to eluci-
date. We expect a fair survival in our present case after
surgery and chemotherapy, while close follow-up and
monitor by AFP levels are recommended.
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